{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:14:01Z","timestamp":1767849241905,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier","isbn-type":[{"value":"9780443317842","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD110500"],"award-info":[{"award-number":["R01 HD110500"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.mie.2025.01.071","type":"book-chapter","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:22:06Z","timestamp":1740558126000},"page":"257-270","source":"Crossref","is-referenced-by-count":1,"title":["Monitoring ODC activity and polyamines in Bachmann-Bupp syndrome patient biological samples"],"prefix":"10.1016","member":"78","reference":[{"issue":"2","key":"10.1016\/bs.mie.2025.01.071_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cid\/cis886","article-title":"Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Medecins Sans Frontieres experience in the Democratic Republic of the Congo","volume":"56","author":"Alirol","year":"2013","journal-title":"Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America"},{"key":"10.1016\/bs.mie.2025.01.071_bib2","article-title":"Nifurtimox-Eflornithine Combination Therapy (NECT) for second-stage gambiense human African trypanosomiasis: MSF experience in the Democratic Republic of the Congo","author":"Alirol","year":"2012","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"1","key":"10.1016\/bs.mie.2025.01.071_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1096-8628(19960712)64:1<50::AID-AJMG7>3.0.CO;2-V","article-title":"X-linked mental retardation with thin habitus, osteoporosis, and kyphoscoliosis: Linkage to Xp21.3-p22.12","volume":"64","author":"Arena","year":"1996","journal-title":"American Journal of Medical Genetics"},{"issue":"3","key":"10.1016\/bs.mie.2025.01.071_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0166-6851(83)90022-1","article-title":"In vivo effects of alpha-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei","volume":"7","author":"Bacchi","year":"1983","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"48","key":"10.1016\/bs.mie.2025.01.071_bib5","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1074\/jbc.TM118.003336","article-title":"Polyamine synthesis as a target of MYC oncogenes","volume":"293","author":"Bachmann","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2025.01.071_bib6","first-page":"91","article-title":"Neuroblastoma: Ornithine decarboxylase and polyamines are novel targets for therapeutic intervention","volume":"Vol. 1","author":"Bachmann","year":"2012"},{"key":"10.1016\/bs.mie.2025.01.071_bib7","series-title":"Polyamine drug discovery","first-page":"257","article-title":"Clinical applications of polyamine-based therapeutics","author":"Bachmann","year":"2012"},{"issue":"4","key":"10.1016\/bs.mie.2025.01.071_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/dmcn.15687","article-title":"Bachmann-Bupp syndrome and treatment","volume":"66","author":"Bachmann","year":"2024","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"12","key":"10.1016\/bs.mie.2025.01.071_bib9","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1002\/ajmg.a.40523","article-title":"Novel de novo pathogenic variant in the ODC1 gene in a girl with developmental delay, alopecia, and dysmorphic features","volume":"176","author":"Bupp","year":"2018","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"5","key":"10.1016\/bs.mie.2025.01.071_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd2243","article-title":"Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases","volume":"6","author":"Casero","year":"2007","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.mie.2025.01.071_bib11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","article-title":"Polyamine metabolism and cancer: Treatments, challenges and opportunities","volume":"18","author":"Casero","year":"2018","journal-title":"Nature Reviews. Cancer"},{"issue":"12","key":"10.1016\/bs.mie.2025.01.071_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.ejhg.5201072","article-title":"X-linked spermine synthase gene (SMS) defect: The first polyamine deficiency syndrome","volume":"11","author":"Cason","year":"2003","journal-title":"European Journal of Human Genetics: EJHG"},{"issue":"9","key":"10.1016\/bs.mie.2025.01.071_bib13","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/ijc.25074","article-title":"The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification","volume":"126","author":"Geerts","year":"2010","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"10","key":"10.1016\/bs.mie.2025.01.071_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrc1454","article-title":"Polyamines and cancer: Old molecules, new understanding","volume":"4","author":"Gerner","year":"2004","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.mie.2025.01.071_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-023-02525-2","article-title":"Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: A New Approaches to Neuroblastoma Therapy trial","author":"Hogarty","year":"2024","journal-title":"British Journal of Cancer"},{"issue":"8","key":"10.1016\/bs.mie.2025.01.071_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41568-022-00473-2","article-title":"Polyamines in cancer: Integrating organismal metabolism and antitumour immunity","volume":"22","author":"Holbert","year":"2022","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.mie.2025.01.071_bib17","first-page":"1040","article-title":"Observationes D. Anthonii Lewenhoeck, de natis e semine genitali aminalculis","volume":"12","author":"Lewenhoeck","year":"1677","journal-title":"Philosophical Transactions"},{"issue":"1","key":"10.1016\/bs.mie.2025.01.071_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1940-6207.CAPR-08-0042","article-title":"Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: A randomized placebo-controlled, double-blind trial","volume":"1","author":"Meyskens","year":"2008","journal-title":"Cancer Prevention Research (Phila)"},{"key":"10.1016\/bs.mie.2025.01.071_bib19","first-page":"JCO2202875","article-title":"Eflornithine as postimmunotherapy maintenance in high-risk neuroblastoma: Externally controlled, propensity score-matched survival outcome comparisons","author":"Oesterheld","year":"2023","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"9683","key":"10.1016\/bs.mie.2025.01.071_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: A multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.mie.2025.01.071_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/bjc.2013.15","article-title":"Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas","volume":"108","author":"Raj","year":"2013","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.mie.2025.01.071_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67097","article-title":"Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease","volume":"10","author":"Rajasekaran","year":"2021","journal-title":"Elife"},{"issue":"5","key":"10.1016\/bs.mie.2025.01.071_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127246","article-title":"A phase I trial of DFMO targeting polyamine addiction in patients with relapsed\/refractory neuroblastoma","volume":"10","author":"Saulnier Sholler","year":"2015","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/bs.mie.2025.01.071_bib24","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1042\/BCJ20190294","article-title":"Biochemical features of primary cells from a pediatric patient with a gain-of-function ODC1 genetic mutation","volume":"476","author":"Schultz","year":"2019","journal-title":"The Biochemical Journal"},{"key":"10.1016\/bs.mie.2025.01.071_bib25","unstructured":"Schwartz, C. E., Peron, A., & Kutler, M. J. (2020). Snyder-robinson syndrome. In M. P. Adam, G. M. Mirzaa, R. A. Pagon, S. E. Wallace, L. J. H. Bean, K. W. Gripp, & A. Amemiya (Eds.), GeneReviews (R). Seattle, WA, 1993\u20132024."},{"issue":"1","key":"10.1016\/bs.mie.2025.01.071_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32659-w","article-title":"Maintenance DFMO increases survival in high risk neuroblastoma","volume":"8","author":"Sholler","year":"2018","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.mie.2025.01.071_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jnci\/93.1.57","article-title":"Alpha-difluoromethylornithine and polyamine levels in the human prostate: Results of a phase IIa trial","volume":"93","author":"Simoneau","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"issue":"11","key":"10.1016\/bs.mie.2025.01.071_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/000992286900801114","article-title":"Recessive sex-linked mental retardation in the absence of other recognizable abnormalities. Report of a family","volume":"8","author":"Snyder","year":"1969","journal-title":"Clinical Pediatrics (Phila)"},{"issue":"36","key":"10.1016\/bs.mie.2025.01.071_bib29","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/sj.onc.1208808","article-title":"Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells","volume":"24","author":"Wallick","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/bs.mie.2025.01.071_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-4632.2006.03079.x","article-title":"Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair","volume":"46","author":"Wolf","year":"2007","journal-title":"International Journal of Dermatology"}],"container-title":["Methods in Enzymology","Enzymes of Polyamine Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687925001132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687925001132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:25:13Z","timestamp":1762230313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0076687925001132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443317842"],"references-count":30,"URL":"https:\/\/doi.org\/10.1016\/bs.mie.2025.01.071","relation":{},"ISSN":["0076-6879"],"issn-type":[{"value":"0076-6879","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}